Surmodics (SRDX) News Today $26.97 -0.67 (-2.42%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$26.94 -0.02 (-0.09%) As of 05/5/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Analysts Set Expectations for Surmodics Q3 EarningsMay 6 at 2:45 AM | americanbankingnews.comBarrington Research Forecasts Surmodics Q3 EarningsSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Investment analysts at Barrington Research issued their Q3 2025 earnings per share estimates for Surmodics in a research report issued to clients and investors on Thursday, May 1st. Barrington Research analyst M. Petusky forecasts that the company wilMay 6 at 2:19 AM | marketbeat.comSurmodics Q2 EPS Estimate Decreased by Barrington ResearchSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Equities researchers at Barrington Research dropped their Q2 2026 earnings per share estimates for Surmodics in a research report issued to clients and investors on Thursday, May 1st. Barrington Research analyst M. Petusky now forecasts that the compaMay 4 at 8:47 AM | marketbeat.comFY2025 EPS Estimates for Surmodics Decreased by AnalystSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Analysts at Zacks Research lowered their FY2025 earnings estimates for shares of Surmodics in a research report issued to clients and investors on Tuesday, April 29th. Zacks Research analyst D. Dey now anticipates that the company will earn ($0.02) peMay 4 at 8:11 AM | marketbeat.comAQR Arbitrage LLC Has $8.16 Million Position in Surmodics, Inc. (NASDAQ:SRDX)AQR Arbitrage LLC lifted its position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 56.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 205,956 shares of the company's stock after acquiring anMay 3 at 8:10 AM | marketbeat.comWhat is Zacks Research's Estimate for Surmodics Q3 Earnings?Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Equities researchers at Zacks Research reduced their Q3 2025 earnings per share estimates for Surmodics in a note issued to investors on Tuesday, April 29th. Zacks Research analyst D. Dey now expects that the company will earn $0.00 per share for theMay 3 at 7:45 AM | marketbeat.comBarrington Research Reduces Earnings Estimates for SurmodicsMay 3 at 4:03 AM | americanbankingnews.comResearch Analysts Set Expectations for Surmodics Q3 EarningsMay 3 at 2:35 AM | americanbankingnews.comFY2025 EPS Estimates for Surmodics Reduced by Zacks ResearchMay 3 at 2:35 AM | americanbankingnews.comAre Options Traders Betting on a Big Move in Surmodics Stock?May 2, 2025 | msn.comSurmodics (NASDAQ:SRDX) Earns Hold Rating from Needham & Company LLCNeedham & Company LLC reissued a "hold" rating on shares of Surmodics in a report on Wednesday.May 2, 2025 | marketbeat.comSurmodics (NASDAQ:SRDX) Issues FY 2025 Earnings GuidanceSurmodics (NASDAQ:SRDX) updated its FY 2025 earnings guidance. The company provided EPS guidance of -0.620--0.420 for the period, compared to the consensus estimate of -0.260. The company also issued revenue guidance of $114.0 millionillion-$117.0 millionillion, compared to the consensus estimate of $127.3 millionillion.May 2, 2025 | marketbeat.comOne68 Global Capital LLC Invests $1.09 Million in Surmodics, Inc. (NASDAQ:SRDX)One68 Global Capital LLC acquired a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 27,457 shares of the company's stock, valued at approximaMay 2, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Stock Holdings Increased by Marshall Wace LLPMarshall Wace LLP lifted its stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 231.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 28,135 shares of the company's stock after purchasing an adMay 2, 2025 | marketbeat.comSurmodics (SRDX) to Release Earnings on WednesdaySurmodics (NASDAQ:SRDX) will be releasing its Q2 2025 earnings before the market opens on Wednesday, April 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-4-30-surmodics-inc-stock/)May 1, 2025 | marketbeat.comSurmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial GuidanceApril 30, 2025 | businesswire.comA Look at Surmodics's Upcoming Earnings ReportApril 30, 2025 | benzinga.comBarclays PLC Buys 19,251 Shares of Surmodics, Inc. (NASDAQ:SRDX)Barclays PLC grew its stake in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 21.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,001 shares of the company's stock after buying an additionalApril 29, 2025 | marketbeat.comSurmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30April 28, 2025 | businesswire.comJPMorgan Chase & Co. Increases Stake in Surmodics, Inc. (NASDAQ:SRDX)JPMorgan Chase & Co. grew its position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 20.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 50,990 shares of the company's stock after aApril 27, 2025 | marketbeat.com56,500 Shares in Surmodics, Inc. (NASDAQ:SRDX) Acquired by Credit Industriel ET CommercialCredit Industriel ET Commercial purchased a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 56,500 shares of the company's stock, valued at apprApril 26, 2025 | marketbeat.comCigogne Management SA Acquires Shares of 78,500 Surmodics, Inc. (NASDAQ:SRDX)Cigogne Management SA bought a new position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 78,500 shares of the company's stock, valued at approximately $3,109,000. SurmodiApril 26, 2025 | marketbeat.comAlpine Global Management LLC Makes New $1.98 Million Investment in Surmodics, Inc. (NASDAQ:SRDX)Alpine Global Management LLC bought a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 50,000 shares of the company's stock,April 24, 2025 | marketbeat.comClearAlpha Technologies LP Acquires 10,000 Shares of Surmodics, Inc. (NASDAQ:SRDX)ClearAlpha Technologies LP lifted its holdings in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 19.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 60,152 shares of the companApril 23, 2025 | marketbeat.comSurmodics publishes TRANSCEND trial dataApril 22, 2025 | markets.businessinsider.comSurmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated BalloonApril 22, 2025 | businesswire.comTrigran Investments Inc. Trims Stock Position in Surmodics, Inc. (NASDAQ:SRDX)Trigran Investments Inc. cut its stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 32.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 368,215 shares of the company's stock after selling 175,127 shares duApril 22, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Sold by Russell Investments Group Ltd.Russell Investments Group Ltd. reduced its position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 41.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 31,618 shares of the company's stock after selling 22,472 shares during the quarter. Russell InvestmenApril 22, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Acquired by Gabelli Funds LLCGabelli Funds LLC increased its stake in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 3.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 339,959 shares of the company's stock aApril 19, 2025 | marketbeat.comNorges Bank Invests $1.25 Million in Surmodics, Inc. (NASDAQ:SRDX)Norges Bank bought a new stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 31,600 shares of the company's stock, valued at approximately $1,251,000. Norges Bank owned 0.22% oApril 14, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Sold by ExodusPoint Capital Management LPExodusPoint Capital Management LP lessened its stake in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 20.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 51,405 shares of the company's stoApril 11, 2025 | marketbeat.comYakira Capital Management Inc. Increases Stock Position in Surmodics, Inc. (NASDAQ:SRDX)Yakira Capital Management Inc. grew its holdings in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 103.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 71,113 shares of the company's stock after purchasing an aApril 8, 2025 | marketbeat.comAlliancebernstein L.P. Sells 29,168 Shares of Surmodics, Inc. (NASDAQ:SRDX)Alliancebernstein L.P. lowered its stake in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 2.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,011,262 shares of the company's stock after selling 29,168 shares during the quarter. AApril 7, 2025 | marketbeat.comBarrington Sticks to Their Hold Rating for SurModics (SRDX)April 5, 2025 | markets.businessinsider.comDLD Asset Management LP Invests $2.51 Million in Surmodics, Inc. (NASDAQ:SRDX)DLD Asset Management LP bought a new stake in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 63,491 shares of the company's stock, vApril 4, 2025 | marketbeat.comSurmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral ArteriesApril 3, 2025 | finance.yahoo.comSurmodics, Inc. (NASDAQ:SRDX) Shares Purchased by Diametric Capital LPDiametric Capital LP boosted its position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 89.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,437 shares of the company's stock after buying anApril 2, 2025 | marketbeat.comSurModics (SRDX) Gets a Hold from BarringtonMarch 31, 2025 | markets.businessinsider.comGardner Lewis Asset Management L P Purchases 49,944 Shares of Surmodics, Inc. (NASDAQ:SRDX)Gardner Lewis Asset Management L P increased its position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 23.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 262,878 shares of the company's stock after purchasing an additional 49,94March 29, 2025 | marketbeat.comBoussard & Gavaudan Investment Management LLP Purchases New Shares in Surmodics, Inc. (NASDAQ:SRDX)Boussard & Gavaudan Investment Management LLP acquired a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 98,375 shares of the company's stock, valued atMarch 29, 2025 | marketbeat.com38,043 Shares in Surmodics, Inc. (NASDAQ:SRDX) Bought by Mint Tower Capital Management B.V.Mint Tower Capital Management B.V. bought a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 38,043 shares of the company's stock, valued at approximately $March 28, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Acquired by Commonwealth of Pennsylvania Public School Empls Retrmt SYSCommonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 165.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 30,000 shares of the company's stoMarch 27, 2025 | marketbeat.comZacks Research Decreases Earnings Estimates for SurmodicsSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Equities research analysts at Zacks Research reduced their FY2027 earnings per share (EPS) estimates for shares of Surmodics in a report issued on Thursday, March 20th. Zacks Research analyst D. Dey now forecasts that the company will post earnings peMarch 24, 2025 | marketbeat.comRoyce & Associates LP Trims Stock Position in Surmodics, Inc. (NASDAQ:SRDX)Royce & Associates LP decreased its stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 36.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 42,305 shares of the company's stock after selling 23,900 shares duringMarch 22, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Short Interest UpdateSurmodics, Inc. (NASDAQ:SRDX - Get Free Report) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 271,300 shares, a drop of 37.0% from the February 13th total of 430,900 shares. Currently, 2.0% of the shares of the company are sold short. Based on an average daily trading volume, of 271,700 shares, the days-to-cover ratio is presently 1.0 days.March 16, 2025 | marketbeat.comLake Street Upgrades Surmodics (SRDX)March 8, 2025 | msn.comLake Street Capital Upgrades Surmodics (NASDAQ:SRDX) to "Buy"Lake Street Capital raised Surmodics from a "hold" rating to a "buy" rating and set a $43.00 price target for the company in a research report on Friday.March 8, 2025 | marketbeat.comFTC sues to block acquisition of SurmodicsMarch 7, 2025 | markets.businessinsider.comSurmodics drops after FTC files suit to block its planned sale to GTCRMarch 7, 2025 | msn.comSurmodics upgraded to Buy from Hold at Lake StreetMarch 7, 2025 | markets.businessinsider.com Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address SRDX Media Mentions By Week SRDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRDX News Sentiment▼0.180.72▲Average Medical News Sentiment SRDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRDX Articles This Week▼323▲SRDX Articles Average Week Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AtriCure News Today Alphatec News Today Integra LifeSciences News Today Orthofix Medical News Today AngioDynamics News Today Accuray News Today Rockwell Medical News Today ReShape Lifesciences News Today Abbott Laboratories News Today Intuitive Surgical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRDX) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SRDX Stock Free SRDX Stock Alerts